.
.

.
.
the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia..
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the